Clinical Trials on Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in New Zealand
Total 313 results
-
CSL BehringCompletedPolyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)United States, Japan, Australia, Canada, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
argenxCompletedChronic Inflammatory Demyelinating Polyneuropathy (CIDP)United States, Austria, Belgium, Bulgaria, China, Czechia, Denmark, France, Georgia, Germany, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Taiwan, Turkey, Ukraine, United Kingdom
-
Rutgers, The State University of New JerseyRecruitingChronic Inflammatory Demyelinating Polyneuropathy | CIDP | Immunoglobulin DeficiencyUnited States
-
argenxActive, not recruitingChronic Inflammatory Demyelinating Polyneuropathy (CIDP)United States, Austria, Belgium, Bulgaria, China, Czechia, Denmark, France, Georgia, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, Spain, Ukraine, United Kingdom, Latvia, Romania, Taiwan, Turkey
-
BiogenCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Australia, Canada, United Kingdom
-
Bioverativ, a Sanofi companyActive, not recruitingChronic Inflammatory Demyelinating PolyradiculoneuropathyCanada, Spain, China, Italy, United States, France, Germany, Netherlands, Poland, Serbia
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, United States, Belgium, Germany, Italy, Israel, Australia, France, United Kingdom, Netherlands, Czechia, Japan, Canada, Greece, Poland
-
Grifols Therapeutics LLCCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
-
State University of New York at BuffaloFichte, Endl & Elmer Eyecare; Dent Neurological Institute, Buffalo, NYCompletedChronic Inflammatory Demyelinating PolyneuropathyUnited States
-
University of MinnesotaCSL Behring; BriovaRx Infusion ServicesCompletedChronic Inflammatory Demyelinating PolyneuropathyUnited States
-
CSL BehringICON Clinical ResearchCompletedPolyradiculoneuropathy | Chronic Inflammatory Demyelinating PolyneuropathyUnited States, Australia, Belgium, Canada, Czechia, Estonia, Finland, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Spain, United Kingdom
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
Janssen Research & Development, LLCRecruitingPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, China, Taiwan, Korea, Republic of, Japan, France, Spain, Czechia, Poland, Greece, United Kingdom
-
Immunovant Sciences GmbHRecruitingChronic Inflammatory Demyelinating PolyneuropathyUnited States, Italy, Norway, Greece, Poland, Sweden, Argentina, Belgium, Denmark, Finland, Germany, Portugal, Romania, Slovakia, Spain, Bulgaria, Korea, Republic of, United Kingdom
-
PfizerTerminatedHealthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune ThrombocytopeniaSpain, United States, Belgium, United Kingdom, New Zealand
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Gilead SciencesCompletedUlcerative ColitisNew Zealand
-
Bridge Biotherapeutics, Inc.CovanceTerminatedUlcerative ColitisNew Zealand
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Zealand University HospitalRecruiting
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
NYU Langone HealthWithdrawnInflammatory Bowel DiseaseUnited States
-
Brainstorm-Cell TherapeuticsCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
AmgenTerminatedUlcerative ColitisUnited States, Australia, New Zealand
-
American Laboratory Products CompanyMDC Associates, LLCCompletedIrritable Bowel Syndrome | Inflammatory Bowel DiseasesUnited States
-
NYU Langone HealthCompleted
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
NYU Langone HealthCompletedMultiple Sclerosis | Chronic Pain | Neurological DisorderUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
PfizerWithdrawnInflammatory Bowel DiseaseUnited States
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of RochesterEndo PharmaceuticalsTerminatedMultiple Sclerosis | Chronic Pain | Neuropathic PainUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
RWTH Aachen UniversityCompletedChronic Inflammatory Intestinal Diseases (CED)Germany
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Eli Lilly and CompanyRecruitingInflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis | Ulcerative Colitis ChronicUnited States, Korea, Republic of, Poland, Italy, Japan
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
Renal Research InstituteAbbottCompletedCardiovascular Disease | Hemodialysis | End Stage Renal Disease | Inflammatory ResponseUnited States
-
Icahn School of Medicine at Mount SinaiCompletedInflammatory Bowel Diseases | Ulcerative ColitisUnited States
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsActive, not recruitingInflammatory Bowel Diseases | Ulcerative ColitisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Dartmouth-Hitchcock Medical CenterUniversity of OtagoCompletedChronic Pain | Inflammatory Bowel Diseases | Central SensitizationUnited States
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
PredictImmune LtdCrohn's and Colitis FoundationRecruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | IBDUnited States